Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All nigella sativa studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchNigella SativaNigella Sativa (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Exploring the Potency of Nigella sativa Seed in Inhibiting SARS-CoV-2 Main Protease Using Molecular Docking and Molecular Dynamics Simulations

Hardianto et al., Indonesian Journal of Chemistry, doi:10.22146/ijc.65951
Jul 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
11th treatment shown to reduce risk in January 2021
 
*, now known with p = 0.00016 from 14 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
In Silico study showing nigella sativa metabolites binding to SARS-CoV-2 Mpro.
Hardianto et al., 12 Jul 2021, peer-reviewed, 5 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
This PaperNigella SativaAll
Exploring the Potency of Nigella sativa Seed in Inhibiting SARS-CoV-2 Main Protease Using Molecular Docking and Molecular Dynamics Simulations
Ari Hardianto, Muhammad Yusuf, Ika Wiani Hidayat, Safri Ishmayana, Ukun Mochammad Syukur Soedjanaatmadja
Indonesian Journal of Chemistry, doi:10.22146/ijc.65951
Coronavirus disease (COVID-19) is a pandemic burdening the global economy. It is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Black cumin (Nigella sativa) seed may contain antivirals for the disease since it was reported to inhibit the human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Main protease (M pro ) is a vital protein for viral replication and a promising target for COVID-19 drug development. Hence, in this study, we intended to uncover the potency of N. sativa seed as the natural source of inhibitors for SARS-CoV-2 M pro . We collected secondary metabolites in N. sativa seed through a literature search and employed Lipinski's rule of five as the initial filter. Subsequently, virtual screening campaigns using a molecular docking method were performed, with N3 inhibitor and leupeptin as reference ligands. The top hits were analyzed further using a molecular dynamics simulation approach. Molecular dynamics simulations showed that binding affinities of nigellamine A2 and A3 to M pro are comparable to that of leupeptin, with median values of -43.9 and -36.2 kcal mol -1 , respectively. Ultimately, this study provides scientific information regarding N. sativa seeds' potency against COVID-19 and helps direct further wet experiments.
References
Ahmad, Husain, Mujeeb, Khan, Najmi et al., A review on therapeutic potential of Nigella sativa: A miracle herb, Asian Pac. J. Trop. Biomed
Ashraf, Ashraf, Ashraf, Imran, Kalsoom et al., Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial, medRxiv
Bouchentouf, Missoum, Identification of compounds from Nigella Sativa as new potential inhibitors of 2019 novel Coronasvirus (Covid-19), Molecular docking study
Case, Aktulga, Belfon, Ben-Shalom, Brozell et al., Amber 2020
Egbert, Whitty, Keserű, Vajda, Why some targets benefit from beyond rule of five drugs, J. Med. Chem
Ferdian, Elfirta, Emilia, Ikhwani, Inhibitory potential of black seed (Nigella sativa L.) bioactive compounds towards main protease of SARS-CoV-2: In silico study, Ann. Bogor
Forli, Huey, Pique, Sanner, Goodsell et al., Computational protein-ligand docking and virtual drug screening with the AutoDock suite, Nat. Protoc
Frisch, Trucks, Schlegel, Scuseria, Robb et al., Gaussian 09 Revision A.02
Gorbalenya, Baker, Baric, De Groot, Drosten et al., The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2, Nat. Microbiol
Hardianto, Khanna, Liu, Ranganathan, Diverse dynamics features of novel protein kinase C (PKC) isozymes determine the selectivity of a fluorinated balanol analogue for PKCϵ, BMC Bioinf
Hardianto, Liu, Ranganathan, Molecular dynamics pinpoint the global fluorine effect in balanoids binding to PKCε and PKA, J. Chem. Inf. Model
Hardianto, Yusuf, Liu, Ranganathan, Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases, BMC Bioinf
Jin, Du, Xu, Deng, Liu et al., Structure of M pro from SARS-CoV-2 and discovery of its inhibitors, Nature
Khan, Afzal, Chemical composition of Nigella sativa Linn: Part 2 Recent advances, Inflammopharmacology
Khan, Siddiqui, Jain, Sonwane, Discovery of potential inhibitors of SARS-CoV-2 (COVID-19) Main Protease (Mpro) from Nigella Sativa (black seed) by molecular docking study, Coronaviruses
Kneller, Galanie, Phillips, O'neill, Coates et al., Malleability of the SARS-CoV-2 3CL M pro activesite cavity facilitates binding of clinical antivirals, Structure
Lipinski, Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions, Adv. Drug Delivery Rev
Maier, Martinez, Kasavajhala, Wickstrom, Hauser et al., ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput
Maiti, Banerjee, Nazmeen, Kanwar, Das, Active-site molecular docking of Nigellidine with nucleocapsid-NSP2-M Pro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella-sativa in experimental rats, J. Drug Targeting
Mathieu, Ritchie, Ortiz-Ospina, Roser, Hasell et al., A global database of COVID-19 vaccinations, Nat. Hum. Behav
Mehta, Pandit, Gupta, New principles from seeds of Nigella sativa, Nat. Prod. Res
Merfort, Wray, Barakat, Hussein, Nawwar et al., Flavonol triglycosides from seeds of Nigella sativa, Phytochemistry
Morikawa, Xu, Ninomiya, Matsuda, Yoshikawa, Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin, Chem. Pharm. Bull
Nickavar, Mojab, Javidnia, Amoli, Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran, Z. Naturforsch
Simmons, Gosalia, Rennekamp, Reeves, Diamond et al., Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc. Natl. Acad. Sci. U.S.A
Singh, Villoutreix, Ecker, Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1), Sci. Rep
Stewart, Application of the PM6 method to modeling proteins, J. Mol. Model
Sumaryada, Pramudita, Molecular docking evaluation of some Indonesian's popular herbals for a possible COVID-19 treatment, Biointerface Res. Appl. Chem
Torres, Sodero, Jofily, Silva, Key topics in molecular docking for drug design, Int. J. Mol. Sci
Who, Pneumonia of unknown cause -China
Who, WHO announces COVID-19 outbreak a pandemic
Worldometers, COVID-19 coronavirus pandemic
Yimer, Tuem, Karim, Ur-Rehman, Anwar, Nigella sativa L. (black cumin): A promising natural remedy for wide range of illnesses, Evidence-Based Complementary, Altern. Med
Yuan, Nahar, Sharma, Liu, Slitt et al., Indazole-type alkaloids from Nigella sativa seeds exhibit antihyperglycemic effects via AMPK activation in vitro, J. Nat. Prod
Yusuf, Hardianto, Muchtaridi, Nuwarda, Subroto, Introduction of Docking-Based Virtual Screening Workflow Using Desktop Personal Computer
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit